On January 18th 2023, Global Health Advocates, together with its partner STOPAIDS published a report series which explored how a lack of transparency in the pharmaceutical industry and the European Union harmed public health outcomes during the Covid-19 pandemic.
Through legal and investigative research, the series uncovered the lack of transparency and set out recommended legal and policy options to ensure those whose responsibility it was to protect the public interest in general, and public health more specifically, are actually in charge of the process. Moreover, it called for decision-makers to be held accountable.
One year on, it appears, sadly, that access is still being denied. Read our statement here.
For more information, please contact Rowan Dunn, EU Advocacy Coordinator at: email@example.com